Current Environment: Production

Stephen Gellis | Medical Services

Programs & Services

Languages

  • English

Stephen Gellis | Education

Undergraduate School

Tufts University

1969, Medford, MA

Medical School

Harvard Medical School

1974, Boston, MA

Internship

Boston Children's Hospital

1974, Boston, MA

Residency

Boston Children's Hospital

1976, Boston, MA

Residency

Dermatology

Massachusetts General Hospital

1978, Boston, MA

Stephen Gellis | Certifications

  • American Board of Dermatology (General)
  • American Board of Dermatology (Pediatric Dermatology)

Stephen Gellis | Professional History

Dr. Stephen Gellis is a master clinician in pediatric dermatology.  He is trained in both pediatrics and dermatology.  He served as Director of the Boston Children's Hospital Dermatology Program for 33 years and has trained and mentored countless pediatricians and dermatologists.  Currently, he practices at the Main Campus in Boston and at our Lexington location.

Stephen Gellis | Publications

  1. Topical corticosteroids for noninvasive treatment of pyogenic granulomas. Pediatr Dermatol. 2021 Nov; 38 Suppl 2:149-151. View Topical corticosteroids for noninvasive treatment of pyogenic granulomas. Abstract

  2. Pediatric facial pyoderma gangrenosum preceding the diagnosis of inflammatory bowel disease. Pediatr Dermatol. 2020 Jul; 37(4):764-766. View Pediatric facial pyoderma gangrenosum preceding the diagnosis of inflammatory bowel disease. Abstract

  3. Clinical features and outcomes of spitzoid proliferations in children and adolescents. Br J Dermatol. 2019 08; 181(2):366-372. View Clinical features and outcomes of spitzoid proliferations in children and adolescents. Abstract

  4. Eosinophilic annular erythema treated with dupilumab. Pediatr Dermatol. 2018 Jul; 35(4):e255-e256. View Eosinophilic annular erythema treated with dupilumab. Abstract

  5. Herpes zoster at the vaccination site in immunized healthy children. Pediatr Dermatol. 2018 Mar; 35(2):230-233. View Herpes zoster at the vaccination site in immunized healthy children. Abstract

  6. Primary Cutaneous B-Cell Lymphoblastic Lymphoma Arising from a Long-Standing Lesion in a Child and Review of the Literature. Pediatr Dermatol. 2017 Jul; 34(4):e182-e186. View Primary Cutaneous B-Cell Lymphoblastic Lymphoma Arising from a Long-Standing Lesion in a Child and Review of the Literature. Abstract

  7. Pediatric Pemphigus Herpetiformis: Case Report and Review of the Literature. Pediatr Dermatol. 2017 May; 34(3):342-346. View Pediatric Pemphigus Herpetiformis: Case Report and Review of the Literature. Abstract

  8. Neurovascular Stains in Two Girls with Neurofibromatosis 1. Pediatr Dermatol. 2016 Mar-Apr; 33(2):e158-9. View Neurovascular Stains in Two Girls with Neurofibromatosis 1. Abstract

  9. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome associated with neonatal epidermolysis bullosa acquisita. Pediatr Dermatol. 2015 May-Jun; 32(3):e74-7. View Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome associated with neonatal epidermolysis bullosa acquisita. Abstract

  10. Rapidly fatal multiorgan Langerhans cell histiocytosis in a neonate. Pediatr Dermatol. 2013 Sep-Oct; 30(5):e85-6. View Rapidly fatal multiorgan Langerhans cell histiocytosis in a neonate. Abstract

  11. A case of recalcitrant epidermolysis bullosa acquisita responsive to rituximab therapy. Pediatr Dermatol. 2014 Mar-Apr; 31(2):241-4. View A case of recalcitrant epidermolysis bullosa acquisita responsive to rituximab therapy. Abstract

  12. Hand, foot, and mouth disease caused by coxsackievirus a6. Emerg Infect Dis. 2012 Oct; 18(10):1702-4. View Hand, foot, and mouth disease caused by coxsackievirus a6. Abstract

  13. Picture of the month-quiz case. Infantile Fibrosarcoma. Arch Pediatr Adolesc Med. 2012 Sep; 166(9):863. View Picture of the month-quiz case. Infantile Fibrosarcoma. Abstract

  14. Agminated atypical Spitz tumor: large nasal lesion in a child with Down syndrome. J Pediatr Surg. 2011 Jul; 46(7):1435-7. View Agminated atypical Spitz tumor: large nasal lesion in a child with Down syndrome. Abstract

  15. Fever, oral ulcerations, arthralgias, neutropenia, and a polycyclic skin eruption in a 14-year-old girl. Pediatr Dermatol. 2009 May-Jun; 26(3):347-8. View Fever, oral ulcerations, arthralgias, neutropenia, and a polycyclic skin eruption in a 14-year-old girl. Abstract

  16. Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia. J Am Acad Dermatol. 2004 Nov; 51(5):718-22. View Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia. Abstract

  17. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest. 2002 Jun; 109(11):1501-9. View Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. Abstract

  18. Psoriatic eruption in Kawasaki disease. J Pediatr. 2000 Oct; 137(4):578-80. View Psoriatic eruption in Kawasaki disease. Abstract

  19. Pioneers and modern ideas. General pediatrics. Pediatrics. 1998 Jul; 102(1 Pt 3):286-7; discussion 288-9. View Pioneers and modern ideas. General pediatrics. Abstract

  20. Epidermolytic hyperkeratosis. Int J Dermatol. 1996 Aug; 35(8):579-81. View Epidermolytic hyperkeratosis. Abstract

  21. Lymphomatoid papulosis in children. J Am Acad Dermatol. 1995 Nov; 33(5 Pt 1):741-8. View Lymphomatoid papulosis in children. Abstract

  22. Neonatal lupus erythematosus and maternal lupus erythematosus mimicking HELLP syndrome. Pediatr Dermatol. 1993 Jun; 10(2):177-81. View Neonatal lupus erythematosus and maternal lupus erythematosus mimicking HELLP syndrome. Abstract

  23. Spirochetes in atrophic skin lesions accompanied by minimal host response in a child with Lyme disease. J Am Acad Dermatol. 1991 Aug; 25(2 Pt 2):395-7. View Spirochetes in atrophic skin lesions accompanied by minimal host response in a child with Lyme disease. Abstract

  24. Bullous diseases of childhood. Dermatol Clin. 1986 Jan; 4(1):89-98. View Bullous diseases of childhood. Abstract

  25. Amino acid metabolism in infectious hepatitis. J Clin Invest. 1954 Dec; 33(12):1603-10. View Amino acid metabolism in infectious hepatitis. Abstract

  26. CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXVI. INACTIVATION OF THE VIRUS OF HOMOLOGOUS SERUM HEPATITIS IN SOLUTIONS OF NORMAL HUMAN SERUM ALBUMIN BY MEANS OF HEAT. J Clin Invest. 1948 Mar; 27(2):239-44. View CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXVI. INACTIVATION OF THE VIRUS OF HOMOLOGOUS SERUM HEPATITIS IN SOLUTIONS OF NORMAL HUMAN SERUM ALBUMIN BY MEANS OF HEAT. Abstract

  27. Chemical, clinical, and immunological studies on the products of human plasma fractionation; inactivation of the virus of homologous serum hepatitis in solutions of normal human serum albumin by means of heat. J Clin Invest. 1948 Mar; 27(2):239-44. View Chemical, clinical, and immunological studies on the products of human plasma fractionation; inactivation of the virus of homologous serum hepatitis in solutions of normal human serum albumin by means of heat. Abstract

  28. STUDIES ON THE RELATIONSHIP OF THE HEPATITIS VIRUS TO PERSISTENT SYMPTOMS, DISABILITY, AND HEPATIC DISTURBANCE ("CHRONIC HEPATITIS SYNDROME") FOLLOWING ACUTE INFECTIOUS HEPATITIS. J Clin Invest. 1947 Mar; 26(2):329-38. View STUDIES ON THE RELATIONSHIP OF THE HEPATITIS VIRUS TO PERSISTENT SYMPTOMS, DISABILITY, AND HEPATIC DISTURBANCE ("CHRONIC HEPATITIS SYNDROME") FOLLOWING ACUTE INFECTIOUS HEPATITIS. Abstract

  29. CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XI. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PROPHYLAXIS AND TREATMENT OF MEASLES. J Clin Invest. 1944 Jul; 23(4):531-40. View CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XI. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PROPHYLAXIS AND TREATMENT OF MEASLES. Abstract

BESbswy
BESbswy